Analyst Ratings for Homology Medicines (FIXX)
FIXX Rating Summary
FIXX Price Target Summary
- Highest: $1.70 (Credit Suisse)
- Lowest: $1.50 (Baird)
- Average: $1.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1.60 (+72%)
* Over Last 12-Mos
Rating Score: 5.4 / 10
Percentile Rank: 58%
Avg. $ Target:
$1.60 (+72%)
* Over Last 12-Mos
Rating Score: 5.4 / 10
Percentile Rank: 58%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2023 | Baird | Jack Allen | Downgrade | Neutral (Outperform) |
1.50 (9.00) |
1.03 (0.93) |
-9.71% | Details |
| 4/28/2022 | Credit Suisse » Updated 8/15/2023 |
Richard Law | New Coverage | Neutral (N/A) |
1.70 (2.00) |
1.61 (0.93) |
-42.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
